Fecal immunochemical test screening found to lower risk of death from colorectal cancer (Medical Xpress)

A recent study indicates that fecal immunochemical tests (FIT) for colorectal cancer screening can significantly reduce mortality rates. The research, published in published online in JAMA Network Open, underscores the effectiveness of FIT in early detection and prevention of colorectal cancer deaths. By implementing widespread FIT screening, healthcare providers can improve patient outcomes and reduce the burden of colorectal cancer.